retatrutide dosing retatrutide clinical trial dose Dosage: What Evidence Currently Shows – Bolt Pharmacy Retatrutide Dosage: A Complete Guide

Limitations Not yet FDA-approved (as of 2025)

In these cases, therapy can be continued

24 weeks 24 syringes 1 syringe per weekly injection

Covers nausea rates from pooled STEP and SURMOUNT data, why patients discontinue, the lean mass question, gallbladder and pancreatitis risk, the thyroid boxed warning, and what happens after stopping

Nassif ME, Windsor SL, Borlaug BA, Kitzman DW, Shah SJ, Tang F, et al

The trial demonstrated dose-dependent weight loss, with participants receiving 12 mg achieving a mean body weight reduction of approximately 24% over 48 weeks a result that has attracted considerable scientific and public interest